Having trouble viewing this email? View in your browser.
Weekly News
7 September 2021

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.

ESCMID Research Grants 2022: Closing tomorrow!

The application period for ESCMID Research Grants 2022 is only open for one more day! The deadline for submitting your applications is 10 September 2021. For this call, only projects dealing with Bacterial Infections & Diseases (incl. diagnostics, pathogenesis, antibacterial susceptibility & resistance, antibacterial stewardship, vaccines) will be accepted. For further information click here and please also see the Research Grants FAQ.

Join one or more of our 32 ESCMID Study Groups!

ESCMID supports 32 Study Groups that cover a wide array of topics and specialties in the fields of clinical microbiology and infectious diseases. Joining a Study Group is free and open to all ESCMID members and opens up many research and networking opportunities. Learn more about them and join on...

ESCMID Online Education Courses: sign up today!

Be sure to secure your place in the exciting ESCMID online education courses coming up in the coming months. Don’t miss highlights such as ‘Paediatric infection management for the microbiologist, antimicrobial pharmacist and specialist in adult infectious diseases’, taking place from 23 - 24...

Participate now in the SurvEthics, from the Ethics Advisory Committee

The Ethics Advisory Committee has launched an anonymous survey to better understand ESCMID members and survey participants' involvement in bioethics and their perceptions of priorities and gaps in the field of bioethics and Infectious Diseases. The results will help the EEAC to better define ethical...

Time to resolution of respiratory and systemic COVID-19 symptoms in community setting

The aim of this study was to evaluate the time to resolution of COVID-19 respiratory and systemic symptoms, and factors associated with a longer duration in a large cohort of outpatients, for whom data is scarce. Results were collected from the over 9000 outpatients, managed by Covidon, a...